Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer.
about
Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialImmunotherapy in human colorectal cancer: Challenges and prospectiveGeneration of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system.Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model.Dominant high expression of wild-type HSP110 defines a poor prognostic subgroup of colorectal carcinomas with microsatellite instability: a whole-section immunohistochemical analysis.
P2860
Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of HLA-A2 or HL ...... otherapy in colorectal cancer.
@en
Identification of HLA-A2 or HL ...... otherapy in colorectal cancer.
@nl
type
label
Identification of HLA-A2 or HL ...... otherapy in colorectal cancer.
@en
Identification of HLA-A2 or HL ...... otherapy in colorectal cancer.
@nl
prefLabel
Identification of HLA-A2 or HL ...... otherapy in colorectal cancer.
@en
Identification of HLA-A2 or HL ...... otherapy in colorectal cancer.
@nl
P2093
P2860
P356
P1433
P1476
Identification of HLA-A2 or HL ...... otherapy in colorectal cancer.
@en
P2093
Hideo Baba
Hiroyuki Komori
Hiroyuki Kuwano
Itaru Endo
Manami Shimomura
Masaaki Ito
Norio Saito
Tetsuya Nakatsura
Yasuharu Nishimura
Yoshiyuki Tsunoda
P2860
P304
P356
10.3892/OR.2013.2941
P577
2013-12-20T00:00:00Z